The Chronicles of CRISPR – Genetic Engineering & Biotechnology News
Posted by btwatson on October 2, 2020 4:07 pm
Tags:
Categories:
CRISPR-Google
The Chronicles of CRISPR – Genetic Engineering & Biotechnology News

Scroll Up
MORE CONTENT
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our privacy policy.
Published at Fri, 02 Oct 2020 07:15:00 +0000
Crispr News
-
Editorial Article: Overcoming the challenges in your gene editing workflow - SelectScienceJuly 7, 2022
-
Pharmalittle: Merck closes in on acquisition of Seagen; Intercept declares victory after re-analyzing NASH data - STATJuly 7, 2022
-
With 'do-over' NASH results, Intercept will seek approval for first-ever treatment for fatty liver condition - STATJuly 7, 2022
-
Virginia Retirement Systems ET AL Boosts Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - Defense WorldJuly 7, 2022
-
Functional Sugar for Food & Beverage Market Size, Share And Forecast to 2028 |BBI Life Sciences, Bio Basic, CRISPR Therapeutics, Caribou Biosciences, DNA 2.0 (ATUM) – Designer Women - Designer WomenJuly 7, 2022
-
Ataxia Market Key Vendors, Opportunities, Deep Analysis By Regional & Country Outlook | Pfizer, Inc., CRISPR Therapeutics, Acorda Therapeutics, Capsida Biotherapeutics Inc., Larimar Therapeutics, …. – Designer Women - Designer WomenJuly 7, 2022
-
Non-CRISPR Gene Editing Platforms Make the Cut … or Avoid Making It - Genetic Engineering & Biotechnology NewsJuly 7, 2022
-
Base Editing: A Strong Contender in Cell and Gene Therapy - Genetic Engineering & Biotechnology NewsJuly 7, 2022
-
Climate change-fighting rice? Plants trap carbon dioxide as they grow — and CRISPR gene editing can optimize this process - Genetic Literacy ProjectJuly 7, 2022
-
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market Report Covers Future Trends With Research 2022-2028 – Designer Women - Designer WomenJuly 6, 2022
-
Tropic Biosciences Raises $35M For Gene-Editing & RNAi Platform Aimed at Developing Tropical Crops - The SpoonJuly 6, 2022
-
A time-resolved, multi-symbol molecular recorder via sequential genome editing - Nature.comJuly 6, 2022
-
A potential danger of CRISPR gene editing—and why base editing may be safer - Phys.orgJuly 6, 2022
-
Global CRISPR and CRISPR-associated (Cas) Genes Market Report 2022-2027 - Growing Investments in R&D Programs by Biotechnology Companies and Non-Profit Organizations - ResearchAndMarkets.com - Business WireJuly 6, 2022
-
Making CRISPR hype more of a reality - Phys.orgJuly 6, 2022
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech